FdaApplication
BLA 761172
Identifiers
- fda_app_no: BLA761172
Properties
| Property | Value |
|---|---|
| applicant_name | Emergent BioDefense Operations Lansing LLC |
| application_type | BLA |
| approval_date | 2020-12-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EBANGA | ANSUVIMAB-ZYKL | 400MG | For Injection |
1 product